Safety of tuberculosis-preventive treatment in children aged under 5 years: A rapid review
Authors:
- Liza Yurie Teruya UchimuraLULiza Yurie Teruya Uchimura
- Tatiana YonekuraTYTatiana Yonekura
- Jeane Roza QuintansJQJeane Roza Quintans
- Mabel Fernandes FigueiróMFMabel Fernandes Figueiró
- Karina dos Santos CasadoKCKarina dos Santos Casado
- Eduardo de Souza AlvesEAEduardo de Souza Alves
- Fernanda Dockhorn Costa JohansenFJFernanda Dockhorn Costa Johansen
- Daniele Maria PelissariDPDaniele Maria Pelissari
- Nicole Menezes de SouzaNSNicole Menezes de Souza
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 59
Abstract
Background: This study aimed to synthesize evidence on the safety of tuberculosis-preventive treatment (TPT) in children aged <5 years, including those with immunocompromising conditions. Methods: A rapid review was conducted using PubMed, Embase, Virtual Health Library, and the Cochrane Library, including systematic reviews and primary studies. Results: Five studies were included, assessing isoniazid-based regimens. Adverse events were mild and reversible, such as transient liver enzyme elevations and peripheral neuropathy. Severe hepatotoxicity was rare and primarily reported in children with Human Immunodeficiency Virus (HIV). Conclusions: TPT appears generally safe in children aged <5 years; however, evidence remains limited for shorter regimens and immunocompromised populations.Keywords
Funding Information
- Program of the Brazilian National Health System
This publication has 9 references indexed in Scilit:
- Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic reviewBMC Infectious Diseases, 2025
- Completion, Safety and Tolerability of Once-weekly Isoniazid and Rifapentine for Tuberculosis Infection by Children and AdolescentsThe Pediatric Infectious Disease Journal, 2025
- Tuberculosis preventive treatment in children and adolescents: an observational study of secondary dataJornal de Pediatria, 2023
- Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the HouseholdOpen Forum Infectious Diseases, 2023
- Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviewsJournal of Clinical Epidemiology, 2021
- A Randomized Controlled Trial of Isoniazid to Prevent Mycobacterium tuberculosis Infection in Kenyan Human Immunodeficiency Virus–Exposed Uninfected InfantsClinical Infectious Diseases, 2020
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or bothBMJ, 2017
- Twice-weekly therapy for children with tuberculosis infection or exposureThe International Journal of Tuberculosis and Lung Disease, 2013
- Safety of long-term isoniazid preventive therapy in children with HIV: a comparison of two dosing schedules.The International Journal of Tuberculosis and Lung Disease, 2013